相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis
Daniela Rossi et al.
JOURNAL OF NEUROLOGY (2018)
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS
Michael Benatar et al.
NEUROLOGY (2018)
Defining SOD1 ALS natural history to guide therapeutic clinical trial design
Taha Bali et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
A case-control study of hormonal exposures as etiologic factors for ALS in women Euro-MOTOR
James P. K. Rooney et al.
NEUROLOGY (2017)
Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review
QianQian Wei et al.
SCIENTIFIC REPORTS (2017)
Pyrimethamine Significantly Lowers Cerebrospinal Fluid Cu/Zn Superoxide Dismutase in Amyotrophic Lateral Sclerosis Patients with SOD1 Mutations
Dale J. Lange et al.
ANNALS OF NEUROLOGY (2017)
Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial
Emma Yates et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
H46R SOD1 mutation is consistently associated with a relatively benign form of amyotrophic lateral sclerosis with slow progression
Zhang-Yu Zou et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China
Lu Chen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis
Satoshi Yamashita et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study
Ching-Hua Lu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis
Bing-Wen Soong et al.
NEUROBIOLOGY OF AGING (2014)
Clinical and genetic heterogeneity of amyotrophic lateral sclerosis
M. Sabatelli et al.
CLINICAL GENETICS (2013)
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (vol 12, pg 435, 2013)
T. M. Miller et al.
LANCET NEUROLOGY (2013)
Genetic analysis and SOD1 mutation screening in Iranian amyotrophic lateral sclerosis patients
Afagh Alavi et al.
NEUROBIOLOGY OF AGING (2013)
Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients
Zhang-Yu Zou et al.
NEUROBIOLOGY OF AGING (2013)
C9orf72 repeat expansions are not detected in Chinese patients with familial ALS
Rong Liu et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Familial amyotrophic lateral sclerosis in Alberta, Canada
Ted Pfister et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
Timothy M. Miller et al.
LANCET NEUROLOGY (2013)
ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics
Olubunmi Abel et al.
HUMAN MUTATION (2012)
SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Faisal Fecto et al.
ARCHIVES OF NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study
Alvaro Alonso et al.
BMC NEUROLOGY (2010)
Mutations of optineurin in amyotrophic lateral sclerosis
Hirofumi Maruyama et al.
NATURE (2010)
Smoking may be considered an established risk factor for sporadic ALS
Carmel Armon
NEUROLOGY (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management
Andrew Eisen et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005
Tameko Kihira et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology:: a genetic and histopathological analysis
Vivianna M. Van Deerlin et al.
LANCET NEUROLOGY (2008)
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Edor Kabashi et al.
NATURE GENETICS (2008)
Lifetime occupation, education, smoking, and risk of ALS
N. A. Sutedja et al.
NEUROLOGY (2007)
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
F Kimura et al.
NEUROLOGY (2006)
Prognosis in amyotrophic lateral sclerosis - A population-based study
MA del Aguila et al.
NEUROLOGY (2003)
分享论文
